// App-Quantinova.ai

: Novel nebulisation of budesonide as add-on treatment in uncontrolled asthmatics

Researchers

Presenter

  • Gary Burgess

Principal Investigators

  • Mark Main

  • Julie Young

  • Alison Scrimgeour

  • Tim Harrison

  • Bernard Muellinger

Medical Centers

  • Vectura Ltd, Chippenham, United Kingdom.

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • Vectura GmbH, Gauting, Germany.

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • FEV

  • Body mass index

Drug/Treatment

  • Budesonide

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved